XML 28 R15.htm IDEA: XBRL DOCUMENT v3.25.1
Goodwill and Other Intangible Assets
 3 Months Ended
Mar. 28, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
The following is a rollforward of the Company’s goodwill ($ in millions):
Balance, December 31, 2024$40,497 
Adjustments due to finalization of purchase price allocations3 
Foreign currency translation and other1,157 
Balance, March 28, 2025$41,657 
The carrying value of goodwill by segment is summarized as follows ($ in millions):
March 28, 2025December 31, 2024
Biotechnology$22,315 $21,437 
Life Sciences12,505 12,305 
Diagnostics6,837 6,755 
Total$41,657 $40,497 
The Company has not identified any “triggering” events which indicate an impairment of goodwill in 2025. The Company has not identified any impairment triggers that resulted in impairments of intangible assets in the first quarter of 2025. The Company will continue to review goodwill and other intangible assets for impairment when events or changes in circumstances, including evolving market conditions and regulatory environment, indicate related carrying amounts may not be recoverable.
During the three-month period ended March 28, 2025, the Company recorded a $15 million impairment related to a facility in the Biotechnology segment.